MDGL
Madrigal Pharmaceuticals Inc
517.00$
+0.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | – | – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | 22.0% | – | – | – | – | – | – | 3.5% | 5.9% | |
| – | – | – | 100.0% | – | – | – | – | – | – | 96.5% | 94.1% | |
| – | – | – | 6,968.6% | – | – | – | – | – | – | 131.4% | 40.5% | |
| – | – | – | 2,192.0% | – | – | – | – | – | – | 241.5% | 84.9% | |
| – | – | – | 9,160.6% | – | – | – | – | – | – | 372.9% | 125.5% | |
| – | – | – | -9,160.6% | – | – | – | – | – | – | -276.4% | -31.3% | |
| – | – | – | 159.4% | – | – | – | – | – | – | 8.1% | 2.3% | |
| – | – | – | -8,901.1% | – | – | – | – | – | – | -258.6% | -30.1% | |
| – | – | – | -181.4% | – | – | – | – | – | – | -258.6% | – | |
| – | – | – | -8,901.1% | – | – | – | – | – | – | -258.6% | -30.1% | |
| – | – | – | -9,138.6% | – | – | – | – | – | – | -249.9% | -27.6% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.